Tyrosine Kinase Inhibitors in the Treatment of Choroidal Metastases from Non-Small-Cell Lung Cancer: A Case Report and Review of Literature

BACKGROUND: Choroidal metastases being the sole presenting feature of lung cancer is rare. Erlotinib, a tyrosine kinase inhibitor (TKI), is used in the treatment of lung adenocarcinoma where tumor cells exhibit epidermal growth factor receptor (EGFR) mutations. We report a case of metastatic non-sma...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Ocul Oncol Pathol
Glavni autori: Nair, Akshay Gopinathan, Asnani, Haresh T., Mehta, Vinod C., Mehta, Siddharth V., Pathak, Rima S., Palkar, Amit H., Gopinathan, Indumati
Format: Artigo
Jezik:Inglês
Izdano: S. Karger AG 2017
Teme:
Case Series and Brief Reports
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5319000/
https://ncbi.nlm.nih.gov/pubmed/28275600
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000448114
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items